Munich - Delayed Quote EUR
Molecure SA (1B1.MU)
1.9700
0.0000
(0.00%)
As of 8:04:09 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-56,990.3190
-56,990.3190
-23,290.0400
-10,213.3830
-13,496.4170
Investing Cash Flow
-23,570.5340
-23,570.5340
-33,873.0890
-33,585.5070
-18,823.3800
Financing Cash Flow
34,760.9150
34,760.9150
55,533.4840
7,377.3600
13,856.7880
End Cash Position
18,188.2020
18,188.2020
63,988.1400
65,617.7850
102,039.3150
Capital Expenditure
-23,774.1500
-23,774.1500
-33,888.1240
-33,631.3500
-18,834.5610
Issuance of Capital Stock
29,716.2380
29,716.2380
49,099.8000
117.0200
4,838.6800
Free Cash Flow
-80,764.4690
-80,764.4690
-57,178.1640
-43,844.7330
-32,330.9780
12/31/2021 - 4/20/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0VQ0.F PureTech Health plc
13.70
+0.74%
6YG.MU Immunocore Holdings plc
26.40
-1.49%
PHR.WA Pharmena S.A.
4.4000
+2.09%
6YG.BE Immunocore Holdings PLC
26.60
-1.48%
OXOA.BE Oxford BioMedica PLC
3.5000
-2.23%
PQB.MU Pure Biologics SA
2.4140
0.00%
9Y4.SG Ryvu Therapeutics SA
7.40
-2.50%
PQB.F Pure Biologics S.A.
2.0560
+1.48%
URT.WA Urteste S.A.
84.80
+6.00%
XI3.F Bioceltix S.A.
23.65
+3.73%